H1 Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 06-11-2024
- Paid Up Capital ₹ 0.10 M
as on 06-11-2024
- Company Age 3 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 168.42%
(FY 2023)
- Profit 170.09%
(FY 2023)
- Ebitda 196.98%
(FY 2023)
- Net Worth 268.68%
(FY 2023)
- Total Assets 64.37%
(FY 2023)
About H1 Life Sciences
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vikram Mamidipudi, Ian Sax, and Debra Schwartz serve as directors at the Company.
- CIN/LLPIN
U72900TG2021FTC147590
- Company No.
147590
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
09 Jan 2021
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at H1 Life Sciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikram Mamidipudi  | Director | 09-Jan-2021 | Current |
Ian Sax  | Director | 09-Jan-2021 | Current |
| Debra Schwartz | Director | 11-Jul-2023 | Current |
Financial Performance of H1 Life Sciences.
H1 Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 168.42% increase. The company also saw a substantial improvement in profitability, with a 170.09% increase in profit. The company's net worth Soared by an impressive increase of 268.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of H1 Life Sciences?
In 2023, H1 Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Facebook India Online Services Private LimitedActive 14 years 8 monthsVikram Mamidipudi is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at H1 Life Sciences?
H1 Life Sciences has a workforce of 260 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of H1 Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped H1 Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
